<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cereb Cortex</journal-id>
<journal-id journal-id-type="iso-abbrev">Cereb. Cortex</journal-id>
<journal-id journal-id-type="publisher-id">cercor</journal-id>
<journal-id journal-id-type="hwp">cercor</journal-id>
<journal-title-group>
<journal-title>Cerebral Cortex (New York, NY)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1047-3211</issn>
<issn pub-type="epub">1460-2199</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26733529</article-id>
<article-id pub-id-type="pmc">6311986</article-id>
<article-id pub-id-type="doi">10.1093/cercor/bhv331</article-id>
<article-id pub-id-type="publisher-id">bhv331</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Disrupted Cortical State Regulation in a Rat Model of Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Berzhanskaya</surname>
<given-names>Julia</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<!--<email>colonnese@gwu.edu</email>-->
<xref ref-type="corresp" rid="d608e99"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Phillips</surname>
<given-names>Marnie A.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gorin</surname>
<given-names>Alexis</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lai</surname>
<given-names>Chongxi</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colonnese</surname>
<given-names>Matthew T.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
</contrib-group>
<aff id="af1">
<label>1</label>
<addr-line>Department of Pharmacology and Physiology and Institute for Neuroscience</addr-line>
</aff>
<aff id="af2">
<label>2</label>
<addr-line>Department of Electrical Engineering</addr-line>
,
<institution>School of Engineering and Applied Sciences, The George Washington University</institution>
,
<addr-line>Washington, DC 20052</addr-line>
,
<country>USA</country></aff>
<author-notes>
<corresp id="d608e99">
Address correspondence to Matthew T. Colonnese, 2300 Eye St NW, Ross Hall 640, Washington, DC 20037, USA. Email:
<email>colonnese@gwu.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date iso-8601-date="2016-01-05" pub-type="epub">
<day>05</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>27</volume>
<issue>2</issue>
<elocation-id>bhv331</elocation-id>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="bhv331.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Children with Fragile X syndrome (FXS) have deficits of attention and arousal. To begin to identify the neural causes of these deficits, we examined juvenile rats lacking the Fragile X mental retardation protein (FMR-KO) for disruption of cortical activity related to attention and arousal. Specifically, we examined the switching of visual cortex between activated and inactivated states that normally occurs during movement and quiet rest, respectively. In both wild-type and FMR-KO rats, during the third and fourth postnatal weeks cortical activity during periods of movement was dominated by an activated state with prominent 18–52 Hz activity. However, during quiet rest, when activity in wild-type rats became dominated by the inactivated state (3–9 Hz activity), FMR-KO rat cortex abnormally remained activated, resulting in increased high-frequency and reduced low-frequency power during rest. Firing rate correlations revealed reduced synchronization in FMR-KO rats, particularly between fast-spiking interneurons, that developmentally precede cortical state defects. Together our data suggest that disrupted inhibitory connectivity impairs the ability of visual cortex to regulate exit from the activated state in a behaviorally appropriate manner, potentially contributing to disrupted attention and sensory processing observed in children with FXS by making it more difficult to decrease cortical drive by unattended stimuli.</p>
</abstract>
<kwd-group>
<kwd>attention</kwd>
<kwd>autism</kwd>
<kwd>cortex</kwd>
<kwd>development</kwd>
<kwd>EEG</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Eye Institute</named-content>
<named-content content-type="funder-identifier">10.13039/100000053</named-content>
</funding-source>
<award-id>EY022730</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Center for Advancing Translational Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100006108</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="15"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>